Arterial Occlusive Diseases
"Arterial Occlusive Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Descriptor ID |
D001157
|
| MeSH Number(s) |
C14.907.137
|
| Concept/Terms |
Arterial Occlusive Diseases- Arterial Occlusive Diseases
- Arterial Occlusive Disease
- Disease, Arterial Occlusive
- Diseases, Arterial Occlusive
- Occlusive Disease, Arterial
- Occlusive Diseases, Arterial
- Arterial Obstructive Diseases
- Arterial Obstructive Disease
- Disease, Arterial Obstructive
- Diseases, Arterial Obstructive
- Obstructive Disease, Arterial
- Obstructive Diseases, Arterial
|
Below are MeSH descriptors whose meaning is more general than "Arterial Occlusive Diseases".
Below are MeSH descriptors whose meaning is more specific than "Arterial Occlusive Diseases".
This graph shows the total number of publications written about "Arterial Occlusive Diseases" by people in this website by year, and whether "Arterial Occlusive Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2009 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Arterial Occlusive Diseases" by people in Profiles.
-
Gonzalez-Cadavid NF, Rajfer J. The two phases of the clinical validation of preclinical translational mechanistic research on PDE5 inhibitors since Viagra's advent. A personal perspective. Int J Impot Res. 2019 Mar; 31(2):57-60.
-
Han J, Saraf SL, Zhang X, Gowhari M, Molokie RE, Hassan J, Alhandalous C, Jain S, Younge J, Abbasi T, Machado RF, Gordeuk VR. Patterns of opioid use in sickle cell disease. Am J Hematol. 2016 Nov; 91(11):1102-1106.
-
Guo ZN, Xu L, Hu Q, Matei N, Yang P, Tong LS, He Y, Guo Z, Tang J, Yang Y, Zhang JH. Hyperbaric Oxygen Preconditioning Attenuates Hemorrhagic Transformation Through Reactive Oxygen Species/Thioredoxin-Interacting Protein/Nod-Like Receptor Protein 3 Pathway in Hyperglycemic Middle Cerebral Artery Occlusion Rats. Crit Care Med. 2016 06; 44(6):e403-11.
-
Felicilda-Reynaldo RF. Circulation savers: thrombolytic therapy. Medsurg Nurs. 2013 Nov-Dec; 22(6):393-7.
-
Hughes K, Padilla L, Al-Zubeidy B, Bolorunduro O, Rose D, Cornwell E, Turner P, Greene W. Diabetes is not associated with an increased peri-operative mortality or non-infectious morbidity following lower extremity arterial reconstruction. Am J Surg. 2014 Apr; 207(4):573-7.
-
Guo Q, Wang G, Namura S. Fenofibrate improves cerebral blood flow after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab. 2010 Jan; 30(1):70-8.
-
Hsia J, Criqui MH, Herrington DM, Manson JE, Wu L, Heckbert SR, Allison M, McDermott MM, Robinson J, Masaki K. Conjugated equine estrogens and peripheral arterial disease risk: the Women's Health Initiative. Am Heart J. 2006 Jul; 152(1):170-6.